Home/Filings/4/0001179110-22-001332
4//SEC Filing

Williamson Douglas J 4

Accession 0001179110-22-001332

CIK 0001012477other

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 4:40 PM ET

Size

5.6 KB

Accession

0001179110-22-001332

Insider Transaction Report

Form 4
Period: 2022-02-14
Williamson Douglas J
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-02-14+275,000275,000 total
    Exercise: $6.60Exp: 2032-02-14ADSs (275,000 underlying)
Footnotes (2)
  • [F1]Options become exercisable as to 68,750 ADSs on each of the first four anniversaries after the 2/14/2022 grant date.
  • [F2]The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.

Issuer

AVADEL PHARMACEUTICALS PLC

CIK 0001012477

Entity typeother

Related Parties

1
  • filerCIK 0001911501

Filing Metadata

Form type
4
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 4:40 PM ET
Size
5.6 KB